Animal Health Angels

Animal Health Angels is an angel investment firm dedicated to fostering innovation and progress within the animal health sector. The firm connects early-stage animal health businesses with a network of experienced angel investors, providing not only capital but also mentorship and strategic guidance. Their mission is to empower visionary entrepreneurs who are developing solutions to improve animal healthcare, promoting true innovation and connecting like-minded leaders across the industry. They focus on high-risk investment opportunities in businesses poised to make significant advancements in animal well-being.

Founded in 2023, Animal Health Angels emerged during a period of rapid technological shifts in the animal healthcare landscape. The firm was established with the belief that collaboration and innovation are crucial for driving positive change in the industry. Its founders, a team of seasoned professionals with extensive backgrounds in veterinary and animal health care across the UK and Europe, came together to create a platform that bridges the gap between innovative startups and the resources needed to fuel their growth.

Animal Health Angels has built a portfolio of promising companies in the animal health space. Notable investments include FluoretiQ Limited, which won 1st Place at the Hong Kong MedTech Innovation World Cup® 2026, and Photon Therapeutics, recognized with a Technology and Innovation Award at the AHNTI EU Innovation Showcase 2026. The firm also supported BioAZ in a $1M fundraising round to accelerate biotech innovation for animal well-being. Other portfolio companies mentioned include Marleybones, MI:RNA Diagnostics, and SageTech Medical Equipment.

The firm's strength lies in its diverse and experienced founding team, which includes Matthew Dobbs, Mark C Binns, Christophe Magaud, Wendy Furness, and Jamie Crittall, along with Director Nick Park. These individuals bring decades of industry expertise spanning veterinary practice, pharmaceuticals, agri-tech, and business leadership. Their collective background encompasses clinical practice, academia, corporate management, and successful entrepreneurial ventures, providing a robust foundation of knowledge and a deep understanding of the animal health market to support their portfolio companies and angel investors.